Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC28H57N4O5P |
InChIKeyUEQLLBPSWJAASZ-UHFFFAOYSA-N |
CAS Registry179458-19-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | US | - |